RxDoctor Payments Data

Gene Roffers, DO

Family Medicine · San Antonio, TXNPI 1508186941

Payments from drug & device makers

$1,918in general payments, 2019–2025

Across 110 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$599
  • Novo Nordisk$296
  • AstraZeneca$266
  • GSK$131
  • Novartis$106
  • Lilly USA, LLC$98
  • plus $421 from 11 others

What the payments were for

  • Food & beverage$1,918100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,918 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$90,847
Medicare patients
300
Services billed
1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$30,759
EliquisApixaban32$23,060
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$20,433
JanuviaSitagliptin Phosphate14$20,192
TrulicityDulaglutide15$19,157
Tresiba Flextouch U-100Insulin Degludec17$14,196
OzempicSemaglutide14$11,965
Breo ElliptaFluticasone/Vilanterol17$8,799
VascepaIcosapent Ethyl14$8,412
LinzessLinaclotide12$7,476
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,900
Gabapentin104$2,821
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen93$2,667
Albuterol Sulfate HfaAlbuterol Sulfate52$1,960
Duloxetine Hcl26$1,944

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$92$30,75920 claims
GSKTrelegy Ellipta, Breo Ellipta$131$29,23232 claims
PfizerEliquis, Premarin$76$24,99850 claims
MerckJanuvia$14$20,19214 claims
Lilly USA, LLCTrulicity$98$19,15715 claims
Novo NordiskOzempic$296$11,96514 claims
AbbVieLinzess, Synthroid$599$8,51527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →